The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments
Authors:
- K.P. WesnesKWK.P. Wesnes
- S.D. KeysSKS.D. Keys
- M.B. WalkerMWM.B. Walker
- J. LolleyJLJ. Lolley
- O. EreminOEO. Eremin
- 1 December 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer
- Vol. 32 (13) , 2275-2283
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Interleukin 2 therapy: current role in surgical oncological practiceBritish Journal of Surgery, 1993
- Residual acute confusional and hallucinatory syndromes induced by interleukin‐2/α‐interferon treatmentPsycho-Oncology, 1992
- The cognitive drug research computerized assessment system for demented patients: A validation studyInternational Journal of Geriatric Psychiatry, 1991
- The effect of intravenous interleukin-2 on brain water contentJournal of Neurosurgery, 1989
- EFFECTS OF TEMAZEPAM PREMEDICATION ON COGNITIVE RECOVERY FOLLOWING ALFENTANIL—PROPOFOL ANAESTHESIABritish Journal of Anaesthesia, 1989
- An investigation of the range of cognitive impairments induced by scopolamine 0·6 mg s.cHuman Psychopharmacology: Clinical and Experimental, 1988
- The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer CellsAnnals of Internal Medicine, 1987
- The effects of practice on measures of performanceHuman Psychopharmacology: Clinical and Experimental, 1987
- The effects of cigarettes of varying yield on rapid information processing performancePsychopharmacology, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975